Status:
RECRUITING
Evaluation of Pain Levels by Quantitative Pupillometry During the Placement of Deep Venous Catheters in Sedated Patients in Intensive Care Unit (PUPICAT)
Lead Sponsor:
Centre Hospitalier Régional Universitaire de Tours
Collaborating Sponsors:
Centre Hospitalier Régional d'Orléans
Conditions:
Critical Illness
Eligibility:
All Genders
18+ years
Brief Summary
Pain is common in intensive care and gives rise to multiple consequences that can impact the future of patients. The placement of deep venous catheters are painful gestures of common practice in inten...
Detailed Description
Three groups of patients will be studied : with aminergic drugs / with curare / without aminergic drugs nor curare. The measurement of pain levels by quantitative pupillometry (NPi®-200 pupillometer,...
Eligibility Criteria
Inclusion
- Patient aged over 18 hospitalized in Intensive Care Unit
- Requiring the placement of a deep venous catheter (central venous catheter or dialysis catheter)
- Sedated, intubated, unable to communicate about pain
- No opposition to participation in the study
Exclusion
- Any ophthalmological pathology (lesion of the orbital cavity, edematous soft tissue or with an open lesion)
- Any intracranial pathology (stroke, subarachnoid hemorrhage, tumour, etc.)
- Patient post-cardio-respiratory arrest within the first 48 hours
- Medicines interfering with the pupillary reflex: clonidine dexmedetomidine, droperidol, metoclopramide, nitric oxide, scopolamine, atropine
- Patient protected within the law
- Previous participation in the study
Key Trial Info
Start Date :
September 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2024
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT05962996
Start Date
September 1 2023
End Date
August 1 2024
Last Update
February 7 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU d'Orléans
Orléans, France, 45000
2
CHRU de Tours
Tours, France, 37000